GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats
The DOI matches its Crossref record; 54 of the 58 references it cites were found in a registry or an index.
Abstract
Control of estrous cycle and reproductive capacity involves a large number of central and peripheral factors, integrating numerous nutritional and metabolic signals. Here we show that glucagon-like peptide-1 (GLP-1), a peptide with anorexigenic and insulinotropic actions, and the GLP-1 receptor agonist Exendin-4 (Ex4) exert a regulatory influence on the gonadal axis, in both adult and prepubertal female rats. In adult rats, Glp-1 receptor expression varies during the estrous cycle at the hypothalamus, pituitary, and ovary. Furthermore, acute treatment with GLP-1 in the morning proestrus doubled the amplitude of the preovulatory LH surge, as well as influencing estradiol and progesterone levels along the estrous cycle. These changes provoked an important increase in the number of Graafian follicles and corpora lutea, as well as in the litter size. Conversely, Ex4 diminished the levels of LH, later producing a partial blockade at the preovulatory surge, yet not affecting either the number of mature follicles or corpora lutea. Chronic administration of low doses of GLP-1 to prepubertal rats synchronized vaginal opening and increased LH levels on the 35th day of life, yet at these doses it did not modify their body weight, food intake, or ovarian and uterine weight. By contrast, chronic exposure to Ex4 produced a significant reduction in ovarian and uterine weight, and serum LH, and the animals treated chronically with Ex4 showed no vaginal opening in the period studied. Overall, our results demonstrate that GLP-1 and Ex4 act on the gonadal axis, involving the hypothalamic kisspeptin system, to influence reproductive efficiency in female rats.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, the chronic exposure to the GLP-1RA Exendin-4 (Ex4) reduced the hypothalamic expression of the kisspetptin-1 (Kiss-1) receptors, with a marked reduction of the preovulatory LH peak and a delayed puberty onset [35].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [35]
In the citing paper
“In addition, the estradiol and progesterone secretion were stimulated, and the number of Graafian follicles and corpora lutea were increased along the estrous cycle [35].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [35]
In the citing paper
“The pituitary gland is located outside the blood–brain barrier and expresses GLP-1 R in both rats and humans [39]. However, a significant direct effect of GLP-1 on pituitary LH release is less likely. In fact, the expression of GLP-1R mRNA in the pituitary was lower than in the hypothalamus and even declined during the estrous cycle [35].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [35]
In the citing paper
“In an in vivo study, the acute treatment with GLP-1 in female rats resulted in the increase of the amplitude of the preovulatory LH surge, likely by the activation of the kisspeptin hypothalamic system, a key regulator of the pulsatile release of GnRH from GnRH neurons [35].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [35]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618
Herrmann, C., Göke, R., Richter, G., Fehmann, H.-C., Arnold, R., & Göke, B. (2009) · Digestion · doi:10.1159/000201231 · Cited by 597
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Thorens, B., Porret, A., Bühler, L., Deng, S.-P., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 558
Leptin's Actions on the Reproductive Axis: Perspectives and Mechanisms
Cunningham, M. J., Clifton, D. K., & Steiner, R. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.2.216 · Cited by 532
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 506
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Salamun, V., Jensterle, M., Janez, A., & Vrtacnik Bokal, E. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0175 · Cited by 204
Liao, B., Qiao, J., & Pang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667422 · Cited by 168
“investigated the effect of GLP-1 on LH synthesis and found that acute administration of GLP-1significantly increases the amplitude of LH surge before ovulation in adult rats, while GLP-1R agonist Exendin-4 can block the stimulatory effect of GLP-1 on LH synthesis (68).”
BackgroundAnti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Diz-Chaves, Y., Mastoor, Z., Spuch, C., González-Matías, L. C., & Mallo, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179583 · Cited by 148
Self-citationThe role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective
Jensterle, M., Janez, A., Fliers, E., DeVries, J. H., Vrtacnik-Bokal, E., & Siegelaar, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz019 · Cited by 128
Xing, C., Zhang, J., Zhao, H., & He, B. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s344542 · Cited by 118
“Acute intracerebral injection of GLP-1 promotes an immediate increase in LH levels before ovulation and significantly increases estrogen and progesterone levels as well as the number of mature follicles.(87) GLP1RA is also expressed in the ovaries, and it significantly suppresses progesterone levels without affecting…”
BackgroundGlucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., Lamas, J. A., & Mallo, F. (2020) · Nutrients · doi:10.3390/nu12113304 · Cited by 84
“Furthermore, the receptor of GLP-1 is expressed by the vagal afferent neurons that innervate the abdominal organs (gastrointestinal tract), including the hepatoportal region [45,46], and also within the nodose ganglion (NG) [46].”
BackgroundSelf-citationGLP-1 and Its Analogs: Does Sex Matter?
Börchers, S., & Skibicka, K. P. (2025) · Endocrinology · doi:10.1210/endocr/bqae165 · Cited by 77
Farkas, I., Vastagh, C., Farkas, E., Bálint, F., Skrapits, K., Hrabovszky, E., Fekete, C., & Liposits, Z. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00214 · Cited by 79
“Thus, direct effect of GLP-1 agonist on GnRH neurons is revealed beside its earlier suggested indirect action via kisspeptin neurons (Outeiriño-Iglesias et al., 2015).”
BackgroundNeuroanatomical Framework of the Metabolic Control of Reproduction
Hill, J. W., & Elias, C. F. (2018) · Physiological Reviews · doi:10.1152/physrev.00033.2017 · Cited by 88
“GLP1 also modulates the reproductive physiology of rodents (201, 342).”
BackgroundMetabolic hormones are integral regulators of female reproductive health and function
Athar, F., Karmani, M., & Templeman, N. M. (2024) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 91
“Early evidence in a rat hypothalamic cell-line pointed to GLP-1 promoting GnRH release via intracellular cAMP signaling [315], and subsequent work implicated the involvement of Kiss1 neurons [314,316,317] and GABAergic signals [318] in bolstering the direct effects of GLP-1 on GnRH neurons.”
BackgroundZhou, L., Qu, H., Yang, L., & Shou, L. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01500-5 · Cited by 66
“For instance, GLP-1 and Exendin-4 can act on the gonadal axis, involving the hypothalamic kiss-1 system, to influence reproductive efficiency in female rats [51].”
BackgroundAbdalla, M. A., Deshmukh, H., Atkin, S., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018821989238 · Cited by 60
Heppner, K. M., Baquero, A. F., Bennett, C. M., Lindsley, S. R., Kirigiti, M. A., Bennett, B., Bosch, M. A., Mercer, A. J., Rønnekleiv, O. K., True, C., et al. (2017) · eneuro · doi:10.1523/eneuro.0198-16.2016 · Cited by 57
“In contrast, a recent publication examined CNS GLP-1R action in prepubertal female rats and demonstrated that low doses of ICV GLP-1 synchronized vaginal opening and increased LH, whereas the GLP-1R agonist exendin-4 inhibited vaginal opening and decreased LH independently of reduced feeding (Outeirino-Iglesias et al.…”
BackgroundMethodResultInfluentialJensterle, M., Herman, R., & Janež, A. (2022) · Biomedicines · doi:10.3390/biomedicines10081989 · Cited by 50
“On the other hand, the expression of GLP-1R on the pituitary gland is significantly lower than in the hypothalamus, therefore, the impact of GLP-1 at the level of the pituitary seems to be predominantly indirect [44,74,75,77].”
BackgroundImbroane, M. R., LeMoine, F., & Nau, C. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.01.019 · Cited by 69
Metabolic control of puberty: 60 years in the footsteps of Kennedy and Mitra’s seminal work
Anderson, G. M., Hill, J. W., Kaiser, U. B., Navarro, V. M., Ong, K. K., Perry, J. R. B., Prévot, V., Tena‐Sempere, M., & Elias, C. F. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00919-z · Cited by 60
“This effect might involve direct actions on kisspeptin neurons 66,67 .”
Sanchez-Garrido, M. A., Serrano-López, V., Ruíz-Pino, F., Vazquez, M. J., Rodríguez-Martín, A., Torres, E., Velasco, I., Rodríguez, A., Chicano‐Gálvez, E., Mora-Ortiz, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52898-y · Cited by 60
“Specific comments along these lines have been added to the revised paper (see page 16, lines 432-441).”
Recent advances in emerging PCOS therapies
Glendining, K. A., & Campbell, R. E. (2023) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102345 · Cited by 51
Acharya, A., Shetty, S. S., & Kumari, S. (2024) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2024.200256 · Cited by 49
Wu, L., Wang, Y.-X., Zhan, Y., Liu, A.-H., Wang, Y., Shen, H., Wang, Y.-F., Wang, L., Tao, Z., & Wang, Y. (2021) · Peptides · doi:10.1016/j.peptides.2021.170624 · Cited by 44
Shao, S., Zhang, X., Xu, Q., Pan, R., & Chen, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108270 · Cited by 46
Fandiño, J., Vaz, A. A., Toba, L., Romaní-Pérez, M., González-Matías, L., Mallo, F., & Diz-Chaves, Y. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6920620 · Cited by 39
“GLP-1 is a gastrointestinal peptide having pleiotropic effects in insulin secretion [20], hypothalamic control of food intake [21], regulation of the hypothalamic-pituitary-adrenal [22–24] and gonadotrophic axis [25], modulation of gastrointestinal motility [26], and regulation of lipid metabolism [27] among others.”
BackgroundSelf-citationGLP-1 increases Kiss-1 mRNA expression in kisspeptin-expressing neuronal cells†
Oride, A., Kanasaki, H., Mijiddorj, T., Sukhbaatar, U., Hara, T., Tumurbaatar, T., & Kyo, S. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox087 · Cited by 42
“A more recent study using a rat in vivo model demonstrated a positive effect of GLP-1 on the amplitude of the preovulatory LH surge, as well as on the number of mature follicles [25].”
BackgroundEffects of Glucagon-like Peptide-1 on the Reproductive Axis in Healthy Men
Izzi‐Engbeaya, C. N., Jones, S., Crustna, Y., Machenahalli, P. C., Papadopoulou, D., Modi, M., Panayi, C., Starikova, J., Eng, P. C., Phylactou, M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa072 · Cited by 41
“In female rats, GLP-1 increases the preovulatory luteinizing hormone (LH) surge (8), but exendin-4 (another GLP-1RA) reduces LH levels (8).”
BackgroundMaternal adaptations to food intake across pregnancy: Central and peripheral mechanisms
Clarke, G. S., Gatford, K. L., Young, R. L., Grattan, D. R., Ladyman, S. R., & Page, A. J. (2021) · Obesity · doi:10.1002/oby.23224 · Cited by 44
The Effects of the New Therapeutic Treatments for Diabetes Mellitus on the Male Reproductive Axis
Pelusi, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.821113 · Cited by 34
“Instead, reduced levels of GLP-1R mRNA in the pituitary have been shown (15), suggesting weak direct effects of GLP-1 at pituitary level.”
BackgroundDíaz-Megido, C., & Thomsen, M. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06367-x · Cited by 34
Gong, B., Li, C., Shi, Z., Wang, F., Dai, R., Chen, G., & Su, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1675552 · Cited by 36
The gut microbiota: emerging biomarkers and potential treatments for infertility-related diseases
Wang, M., Zheng, L., Ma, S., Zhao, D.-H., & Xu, Y. D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1450310 · Cited by 36
Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
Zhu, L., Zhou, J., Pan, Y., Lv, J., Liu, Y., Yu, S., & Zhang, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109555 · Cited by 27
Fathy, M. A., Alsemeh, A. E., Habib, M. A., Abdelnour, H. M., Hendawy, D. M., Eltaweel, A. M., Abdelkhalek, A., Ahmed, M. M., Desouky, M. K., Hua, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1224985 · Cited by 35
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Pugliese, G., de Alteriis, G., Muscogiuri, G., Barrea, L., Verde, L., Zumbolo, F., Colao, A., & Savastano, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02084-6 · Cited by 29
“In fact, the expression of GLP-1R mRNA in the pituitary was lower than in the hypothalamus and even declined during the estrous cycle [35].”
BackgroundInfluentialKhan, D., Ojo, O. O., Woodward, O. R. M., Lewis, J. E., Sridhar, A., Gribble, F. M., Reimann, F., Flatt, P. R., & Moffett, R. C. (2022) · Biomolecules · doi:10.3390/biom12121736 · Cited by 36
Gastrointestinal capacity, gut hormones and appetite change during rat pregnancy and lactation
Johnson, M. L., Saffrey, M. J., & Taylor, V. (2019) · Reproduction · doi:10.1530/rep-18-0414 · Cited by 30
Glintborg, D., Mumm, H., Holst, J. J., & Andersen, M. (2017) · Endocrine Connections · doi:10.1530/ec-17-0034 · Cited by 26
“Treatment with GLP-1 increased LH secretion and induced puberty in female rats (17, 26).”
BackgroundThe hidden impact of GLP ‐1 receptor agonists on endometrial receptivity and implantation
Sola‐Leyva, A., Pathare, A. D. S., Apostolov, A., Aleksejeva, E., Kask, K., Tammiste, T., Ruiz‐Durán, S., Risal, S., Acharya, G., & Salumets, A. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.15010 · Cited by 35
Long-term functional alterations following prenatal GLP-1R activation
Graham, D. L., Madkour, H. S., Noble, B. L., Schatschneider, C. W., & Stanwood, G. D. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106984 · Cited by 25
Cai, J., Yang, W., Chen, D., Zhang, Y., He, Z., Zhang, W., & Zhang, L. (2017) · BMC Genomics · doi:10.1186/s12864-017-3953-6 · Cited by 24
“The expression of glucagon receptor and glucagon-like peptide-1 receptor was detected in the ovary of rat [85, 86].”
BackgroundLiraglutide improves lipid and carbohydrate metabolism of ovariectomized rats
Model, J. F. A., Lima, M. V., Ohlweiler, R., Vogt, É. L., Rocha, D. S., de Souza, S. K., Türck, P., Araújo, A. S. D. R., & Vinagre, A. S. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111158 · Cited by 24
Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review
Monney, M., Mavromati, M., Leboulleux, S., & Gariani, K. (2025) · Endocrine Connections · doi:10.1530/ec-24-0529 · Cited by 30
“An in vivo study on female rats demonstrated that administration of GLP-1 RAs increased the amplitude of LH secretion during the pre-ovulation phase (47).”
Glucagon-like peptide-1 control of GnRH secretion in female sheep
Arbabi, L., Li, Q., Henry, B. A., & Clarke, I. J. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0335 · Cited by 19
“Furthermore, exendin-4 reduced expression of the kisspeptin (Kiss1) (KISS1) and Kiss1 receptor (GPR54) genes in the hypothalamus, with little effect of GLP-1; GLP-1 had a transient stimulatory effect on KISS1 expression only (Outeiriño-Iglesias et al. 2015).”
BackgroundResultInteractions between glucagon like peptide 1 (GLP-1) and estrogens regulates lipid metabolism
Model, J. F. A., Normann, R. S., Vogt, É. L., Dentz, M. C. V., de Amaral, M., Xu, R., Bachvaroff, T. R., Spritzer, P. M., Chung, J. S., & Vinagre, A. S. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116623 · Cited by 22
Liraglutide treatment effects on rat ovarian and uterine tissues
Saber, S., & El‐Rahman, H. A. A. (2019) · Reproductive Biology · doi:10.1016/j.repbio.2019.07.003 · Cited by 18
Mechanisms of probiotic modulation of ovarian sex hormone production and metabolism: a review
Liu, X. D., Chen, X., Wang, C., Song, J., Xu, J., Gao, Z., Huang, Y., & Suo, H. (2024) · Food & Function · doi:10.1039/d3fo04345b · Cited by 21
Sun, S., Liu, S., Luo, J., Chen, Z., Li, C., Loor, J. J., & Cao, Y. (2019) · Reproduction in Domestic Animals · doi:10.1111/rda.13439 · Cited by 18
Tongta, S., Sungkaworn, T., & Pathomthongtaweechai, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210974 · Cited by 21
Human immunodeficiency: Extragonadal comorbidities of infertility in women
Lorzadeh, N., Kazemirad, N., & Kazemirad, Y. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.327 · Cited by 17
Vastagh, C., Farkas, I., Scott, M. M., & Liposits, Z. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02167-7 · Cited by 17
Hoteit, B. H., Kotaich, J., Ftouni, H., Hazime, F., Safawi, A., Masri, R., & Marwani, M. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251383064 · Cited by 21
“69”
InfluentialBeyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children
Zaitoon, H., Wauters, A. D., Rodríguez, L. M., & Lynch, J. L. (2025) · Children · doi:10.3390/children12111427 · Cited by 15
Incretin receptor agonism during pregnancy: implications for mother and baby
Dearden, L., & Ozanne, S. E. (2025) · Clinical Science · doi:10.1042/cs20258493 · Cited by 15
“In rodent models, both endogenous GLP-1 and GLP1RA treatments have been associated with increased preovulatory LH surges, enhanced follicular development and earlier onset of puberty [42].”
Johnson, M. L., Saffrey, M. J., & Taylor, V. (2017) · Peptides · doi:10.1016/j.peptides.2017.02.010 · Cited by 12
Effect of GLP1 Agonists on Reproduction
Couldwell, M., Tidwell, A. J., & Taylor, A. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf401 · Cited by 16
Toffoli, M., Campisciano, G., Santin, A., Pegoraro, S., Zito, G., Spedicati, B., Balduit, A., Romano, F., Lorenzo, G. D., Mangogna, A., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123427 · Cited by 11
Metabolic control of ovarian function through the sympathetic nervous system: role of leptin
Astudillo-Guerrero, C., Paredes, A. H., Escobar, J., Fernandois, D., Barra, R., & Cruz, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1484939 · Cited by 10
Çelik, Ö., Yazıcı, D., Ciudin, A., Macut, D., Micić, D., Yumuk, V., & Yıldız, B. O. (2025) · Obesity Facts · doi:10.1159/000547055 · Cited by 14
“Research in animal models suggests that GLP-1 RAs could help regulate ovarian steroidogenesis and improve follicular development, potentially restoring normal ovulation [67, 68].”
The GLP-1 agonist, exendin-4, stimulates LH secretion in female sheep
Simpson, E. M., Clarke, I. J., Scott, C., Stephen, C., Rao, A., & Gunn, A. J. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0105 · Cited by 13
Alterations in Appetite-Regulating Hormones in Girls with Central Early or Precocious Puberty
Stathori, G., Tzounakou, A.-M., Mastorakos, G. P., Vlahos, N., Charmandari, E., & Valsamakis, G. (2023) · Nutrients · doi:10.3390/nu15194306 · Cited by 13
“Furthermore, the administration of GLP-1 in adult female rats resulted in a significant increase in both kisspeptin and kisspeptin receptor gene expression in the hypothalamus [56].”
BackgroundMerhi, Z. O., Karekar, M., & Mouanness, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326210 · Cited by 8
“Another study showed that the GLP-1 RA Exendin-4 (Ex4) also had an adverse impact on the HPO axis [14] by causing a significant drop in LH levels leading to LH surge suppression via reducing the Kiss-1 and Kiss-1r expression in the hypothalamus and a delay in puberty, as reflected by vaginal…”
Obesity Epidemic and Its Impact on Female Fertility: Current Understanding and Future Directions
Malhotra, R., de Paredes, J. G., Smith, A. C., Chemerinski, A., Doshi, D., & Morelli, S. S. (2025) · Cureus · doi:10.7759/cureus.87283 · Cited by 26
“Mouse studies also demonstrate that GLP-1 influences both estrogen and progesterone levels and increases the number of mature follicles [89,90].”
Gut microbiota: emerging biomarkers and potential therapeutics for premature ovarian failure
Liu, Z., Wang, M., Lei, Y., Xu, K., & Fan, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1606001 · Cited by 9
The dual burden of obesity: decoding metabolism and female reproductive endocrinology
Chen, Y., Wang, R., Zhang, N., & Xu, L. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1627607 · Cited by 12
Izzi‐Engbeaya, C. N., & Dhillo, W. S. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.06.003 · Cited by 8
Does Ozempic boost fertility? What the science says
Dohrn, G. (2024) · Nature · doi:10.1038/d41586-024-02045-w · Cited by 7
Sex differences in GLP-1 signaling across speciesPreprint
Roseberry, T., Grossrubatscher, I., Krausz, T., Wang, Y.-J., Schwartz, M. W., & Tingley, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.17.643822 · Cited by 8
“Critically, the distributed expression of GLP1R and levels of plasma GLP-1 are highly dynamic, and vary in relation to endogenous hormonal fluctuations such as the ovarian cycle 30–32 .”
Commentary: Emerging role of GIP and related gut hormones in fertility and PCOS
Khan, D., & Moffett, R. C. (2020) · Journal of Endocrinological Science · doi:10.29245/2767-5157/2020/1.1109 · Cited by 7
Xiao, Y., Yap, J. A., & Ong, Z. Y. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110640 · Cited by 5
Applebey, S. V., Xiao, A. G., Harris, E. P., Levine, C. M., Belser, D. L., Geisler, C. E., Parent, M. B., Bangasser, D. A., Crist, R. C., Reiner, B. C., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.01.012 · Cited by 6
Predicting treatment response to GLP-1 receptor agonists: still tossing the coin or doing better?
Apostolopoulou, M., & Koufakis, T. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2517802 · Cited by 6
“Interestingly, increased estrogens mediate hypothalamic sensitivity to GLP-1 action, as implied by increased hypothalamic expression of GLP-1 receptors in the late proestrus phase in female rats [7].”
Bolek, T., Turňová, P., Jánošová, S., Péč, M. J., Ságová, I., Nagy, N., Jurica, J., Mokáň, M., & Samoš, M. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.102885 · Cited by 7
Merhi, Z. O. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001044 · Cited by 4
Gut microbiota alterations modulate high-fat diet-induced precocious puberty
Wu, N., Jiang, X., Wang, Y., Zhang, M., Yue, M., Chen, F., Wu, W., Liu, Y., Wang, Q., & Zhang, L. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03264-24 · Cited by 5
Vieyra, E., Silva, C., Linares, R., Rosas, G., Espinoza, J.-A., Chaparro, A., Calderón, R., de la Peña, B., & Morales‐Ledesma, L. (2025) · Molecules · doi:10.3390/molecules30163407 · Cited by 6
Merhi, Z. O. (2024) · F&S Reports · doi:10.1016/j.xfre.2024.12.003 · Cited by 12
“One of the mechanisms by which GLP-1 causes anorexigenic effects is by altering the kisspeptin system at the level of the hypothalamus (18).”
InfluentialA Case of Dulaglutide-Induced Vaginal Bleed
Vaccaro, C. J., Zaidi, S. M. H., Iskander, P. A., & McFadden, E. (2023) · Cureus · doi:10.7759/cureus.38774 · Cited by 6
“It suggested that “GLP-1 regulates the hypothalamic-pituitary-gonadal (HPG) axis by activating the kisspeptin hypothalamic system, which, in turn, increases GnRH levels as a principal mechanism to stimulate LH secretion to increase gonadal steroid circulating levels” [14].”
BackgroundRegulatory cycles of orexin and glucagon-Like peptide-1 in postviral syndromes
Ruhrländer, J., Schieffer, E., & Schieffer, B. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag009 · Cited by 2
Applebey, S. V., Xiao, A. G., Reiner, B. C., & Hayes, M. R. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70177 · Cited by 2
“Similarly, whole hypothalamic Glp1r is increased during late P 41 and may underscore the ability of lateral hypothalamic GLP-1R activation to attenuate food reinforcement in E, but not M/D. 42 Considering these data, we hypothesized that females may demonstrate increased sensitivity to GLP-1RAs in…”
Neuroendocrine Regulation of Puberty
Terasawa, E., & Levine, J. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00106-1 · Cited by 2
Contraception and Diabetes Mellitus
Panou, T., Gouveri, E., Gerede, A., Tsikouras, P. N., Papazoglou, D., & Παπάνας, Ν. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2561-9460 · Cited by 4
“Experimental data from 2015 showed that GLP-1 affected the menstrual cycle in mice by increasing the pre-ovulatory LH peak, thus resulting in an increased number of viable offspring [42].”
GLP-1 Receptor Agonist Use in Pregnancy
Druce, I. (2025) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2025.3139 · Cited by 1
Derkach, K. V., Zorina, I. I., Fedorchuk, I. V., & Shpakov, A. O. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s002209302503007x · Cited by 1
“Along with the thyroid system, GLP-1 and its analogs can influence the gonadal axis [7, 32, 33].”
Food and the brain: Neural and endocrine control of feeding, metabolism, and reproduction
Mansano, N. D. S., Lieu, C. V., & Abizaid, A. B. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70104 · Cited by 4
“76 Overall, these data support the notion that GLP-1 or its agonists can improve fertility.”
Goulet, V., Léveillé, D., Li, J., & Fisette, A. (2026) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-026-00014-7 · Cited by 3
“GLP-1 might modulate the activity of the GnRH neurons found in the hypothalamus [196–199], which are crucial regulators of the reproductive system [126, 200, 201].”
Yan, J., Ma, S.-Z., Chang, S.-Y., Jin, Z.-Y., Liao, X.-X., Ming-xia, J., Kang, J., & Quan, L. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110477 · Cited by 1
Nabeh, O. A., Amr, A., Faoosa, A. M., Esmat, E., Osama, A., Khedr, A. S., Amin, B., Saud, A. I., & Elmorsy, S. A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01585-8 · Cited by 2
Bolze, F., Williams, H., Bhuwania, R., Egecioglu, E., Bloem, E., Paulsson, J. F., Pedersen, M. Ø., Broadmeadow, A., Chesher, C. J., Moore, E. L., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115152 · Cited by 2
Guo, Y., Xie, M., Liu, Y., Huang, J., Wang, Q., & Wang, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1698787/v1 · Cited by 1
Infante, M., & Fabbri, A. (2018) · L Endocrinologo · doi:10.1007/s40619-018-00503-y
Glucagon Like Peptide-1: More than Glucose Control and Weight ReductionPreprint
Chen, Y., Shao, S., Zhang, X., Xu, Q., & Pan, R. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4161722
Pugliese, G., de Alteriis, G., & Savastano, S. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01355-x
刘, 以. (2025) · Traditional Chinese Medicine · doi:10.12677/tcm.2025.146367
Treatment Options for Polycystic Ovary Syndrome
Cai, J., Lü, N., & Ma, J. (2025) · Obstetrics and gynecology. · doi:10.5772/intechopen.1012822 · Cited by 1
Zhou, L., Qu, H., Yang, L., & Shou, L. (2024) · Figshare · doi:10.6084/m9.figshare.26637207
Targeting metabolism to protect fertility and healthy pregnancy with SGLT2 inhibitors and GLP-1RAs
Flanary, S. M., Yoshida, K., Alejandro, E. U., & Townsend, D. (2026) · Current Opinion in Physiology · doi:10.1016/j.cophys.2026.100956
Pharmacological treatment of polyendocrine metabolic ovarian syndrome in adults
Prentice, L., & Rassie, K. L. (2026) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2022.000065 · Cited by 1
Mills, A. M., & Noble, E. E. (2026) · Appetite · doi:10.1016/j.appet.2026.108729
GLP-1 Receptor Agonists and Reproductive Health
Porterfield, F., Mulligan, J., Salim, K., Olubowale, O. O., & Stanford, F. C. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.07.003 · Cited by 1
McNeel, K., Bhanji, Z., Le, V., Lee, J., & Gallicano, I. (2026) · Considerations in Medicine · doi:10.1136/conmed-2026-000096
Metadata
- Authors
- Outeiriño-Iglesias, V., Romaní-Pérez, M., González-Matías, L. C., Vigo, E., & Mallo, F.
- Affiliations
- Laboratory of Endocrinology, Biomedical Research Centre (Centro Investigaciones Biomédicas), University of Vigo, Campus As Lagoas-Marcosende, E-36310 Vigo, Spain; and Institute for Biomedical Research of Vigo, E-36310 Vigo, Spain
- Universidade de Vigo (ES)
- Corresponding author
- Vigo, Eva
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2015-08-07
- Volume
- 156
- Issue
- 11
- Pages
- 4226-4237
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1765565346
- Cited by
- 99
- References
- 58
- Citations by year
- 2026: 8 · 2025: 30 · 2024: 11 · 2023: 11 · 2022: 9 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 3
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministerio de Ciencia e Innovación
- Universidade de Vigo
- FP7 Research Potential of Convergence Regions
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- glucagon-like peptide-1, exendin-4, puberty onset, follicle maturation, kisspeptin, gonadal axis, estrous cycle, estradiol, progesterone, litter size, ovarian weight, uterine weight, female reproduction
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Receptors, Kisspeptin-1, Exenatide, Animals, Estradiol, Female, Follicle Stimulating Hormone, Ovarian Follicle, Luteinizing Hormone, Peptides, Pituitary Gland, Sexual Maturation, Venoms, Rats, Sprague-Dawley, Estrous Cycle, Receptors, G-Protein-Coupled, Rats, Glucagon-Like Peptide 1, Kisspeptins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.